GlassScriptPhysician profile
Lopa D Patel
NPI 1760038608
$930.14
in general payments reported to CMS, 2019-2025
16 companies · $17.98 in 2025
The $17.98 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $277 · 2023: $185 · 2024: $340 · 2025: $17.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $326.26 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $133.19 | 2021-2024 | |
| Rhythm Pharmaceuticals, INC. | $94.30 | 2023-2024 | Imcivree, Imcivree |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.31 | 2022-2024 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $47.88 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.14 | 2022-2024 | Trintellix |
| Exact Sciences Corporation | $29.31 | 2023-2024 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $28.84 | 2021 | |
| Amgen INC. | $28.31 | 2024 | Repatha, Otezla |
| Medtronic, INC. | $24.76 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.07 | 2024 | |
| Medicomp INC | $23.23 | 2024 | Telepatch Cardiac Monitor |
| Xeris Pharmaceuticals, INC. | $17.76 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.97 | 2023 | |
| Horizon Therapeutics Plc | $13.31 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $10.50 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lopa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.